乌罗利:一种新兴的天然化合物,向割抵抗性前列腺癌 (CRPC)
Ajit Kumar Navin1, Chalikkaran Thilakan Rejani2, Balaji Chandrasekaran1
1Department of Pharmacology, College of Pharmacy, Texas A&M University, College Station, TX 77845, USA.
概括
乌罗利通过抑制雄激素受体信号传递和减少氧化应激,在治疗割抵抗性前列腺癌 (CRPC) 中表现有前途. 这些化合物可能提供新的治疗策略,可能与现有治疗方法相结合.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 自然产品 化学 化学
背景情况:
- 抗割前列腺癌 (CRPC) 是由于治疗耐药性的重大临床挑战.
- 雄激素受体 (AR) 信号驱动CRPC的进展.
- 氧化应激有助于CRPC的攻击性.
研究的目的:
- 对CRPC的urolithins的治疗潜力进行审查.
- 阐明在CRPC中乌罗立的作用机制.
- 为了探索涉及urolithins的组合疗法.
主要方法:
- 关于urolithins和CRPC的临床前和临床研究的文献综述.
- 对AR-依赖和AR-独立信号通路的分析.
- 评估乌洛的抗氧化和促丧作用.
主要成果:
- 乌罗利थिन抑制AR信号传递,并表现出抗氧化特性.
- 乌洛素诱导了亡并抑制了CRPC细胞中的亲生存途径.
- 乌罗利显示出瘤抑制作用.
结论:
- 乌罗利是CRPC的一种有前途的治疗类.
- 它们的机制涉及AR依赖和独立的途径.
- 与雄激素切除的联合治疗需要进一步的研究.
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K


